Peripheral Arterial Disease Trial, Recruiting NCT04800276 Sponsor: Centre Hospitalier le Mans Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT04800276
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with peripheral arterial disease (reduced blood flow) in the lower limbs, with a specific test score below 0.90, narrowing of the arteries in the legs, and leg pain or cramping when walking
  • People who have no medical reason preventing them from doing physical activity
  • People aged 18 or over who have social insurance coverage
  • People who have signed the trial consent form

Who may not be able to join:

  • People with serious or unstable heart or lung conditions that make exercise unsafe
  • People who have had unstable chest pain (angina) or a heart attack within the last 3 months
  • People with a severe joint or muscle condition affecting the lower limbs
  • People who have had a limb amputation and use a prosthetic device
  • People with widespread skin disease affecting the lower limbs
  • People with severe heart failure classified at a serious level (NYHA grade III or IV)
  • People with a known severe breathing or lung condition
  • People with Parkinson's disease, paralysis on one side of the body, or paralysis of the lower body
  • Adults who are under enhanced legal protection or who are not free due to a court or government order
  • People who are unable to give their own consent to participate
  • People who are currently taking part in another interventional research study that has an exclusion period
  • People who experience an unexpected event (such as an injury or surgery) during the trial period that could affect the results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 44 71 07 81

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier le Mans
Registry
ClinicalTrials.gov
Start date
11 February 2021
Est. completion
11 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Assess efficacity of Adapted Physical Activity with localization of ischemia on maximum walking distance compared to Adapted Physical activity without localization of ischemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov